Form 4 for MRK Merck & Co.
Accepted 2024-05-02 00:00:00 ET · period of report 2024-04-30 · accession 0001127602-24-013981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-02 | 2024-05-02 | MRK | Smart Dalton | SVP Fin. - Gbl Ctrl | M - OptEx | $128.80 | +381 | 3,048 | +14% | +$49.1K |
| D | 2024-05-02 | 2024-05-02 | MRK | Smart Dalton | SVP Fin. - Gbl Ctrl | F - Tax | $128.80 | -131 | 2,917 | -4% | -$16.9K |
| DM | 2024-05-02 | 2024-04-30 | MRK | Smart Dalton | SVP Fin. - Gbl Ctrl | A - Grant | $0.00 | +8,424 | 1,393 | New | $0 |
| D | 2024-05-02 | 2024-05-02 | MRK | Smart Dalton | SVP Fin. - Gbl Ctrl | M - OptEx | $0.00 | -381 | 764 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | M | A | 381 | $128.80 | 3,048.29 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-02 | F | D | 131 | $128.80 | 2,917.29 | D | — | — | (F1) Includes .041 shares of Merck & Co., Inc. common stock not previously reported due to a clerical error. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-30 | A | A | 7,031 | $0.00 | 7,031 | D | $129.22 · 2025-04-30 to 2034-04-29 | 7,031 Common Stock | (F4) The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. |
| 4 | Derivative | Restricted Stock Unit | 2024-05-02 | M | D | 381 | $0.00 | 764 | D | — · 2024-05-02 to 2026-05-02 | 381 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F5) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026. |
| 5 | Derivative | Restricted Stock Unit | 2024-04-30 | A | A | 1,393 | $0.00 | 1,393 | D | — · 2025-04-30 to 2027-04-30 | 1,393 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. |